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This book is based on a series of articles in the Medical
Journal of Australia "Trials on Trial"; I did not read the orig-
inal articles, but this edited book is of high quality. Its
structure has 22 short chapters essentially based on the 22
item checklist used in the CONSORT statement. The chap-
ters read well generally, although each is written by a dif-
ferent combination of about 2 to 4 of the 22 different
authors, with at least one of the editors. The original
CONSORT statement authors have provided a full paper
explaining and elaborating the reasons for the items in the
checklist, but this book goes further. It is not only a guide
for authors of trial reports but also a very useful book for
anyone studying the science of clinical trials or taking a
course about them.
Standard textbooks on trials give a great deal on how to
plan, design analyse trials but usually have only a limited
amount on how to report them. This book remedies that,
and while there is mention of design issues it concentrates
on how to report a trial clearly.
Each chapter has a brief description of what is required for
the CONSORT item, with some details of how to set these
out and the rationale for ensuring that the information is
included in a report. There are text boxes with a shaded
background in each chapter giving the relevant CONSORT
items, together with pithy quotes, often from the 19th cen-
tury, to illustrate points. One that appealed to me was "to
calculate is not in itself to analyse", Edgar Allan Poe, 1831.
There are a number of boxes containing short items giving
the history of particular early events that relate to trial
methodology. The 16th century, almost accidental, trial
comparing alternative poultices to the standard boiling
oil led to Ambrose Paré being criticised but a powerful
reputation in later life is one example. These help keep a
reader's interest, but many chapters also have a more
detailed, modern, case study which illustrates the key
points being made in a chapter. These are very helpful.
This book does have a few minor problems. It has web ref-
erences, which inevitably fall out of date. The European
Medicines Agency has modified its web addresses so those
quoted in the book are now incorrect, but it is not too dif-
ficult to find the correct ones (usually just changing
"eu.int" to "europa.eu" works). This may well apply to
other web addresses but it is more helpful to give some
reference than not to include web-based material. The dis-
cussion of post-hoc adjustment for baseline imbalance is
not a universally agreed approach and the authors might
consider noting this for a future edition. The statistical sec-
tion is limited and perhaps not always sufficient (handing
of missing data is very weak), but the section on sample
size calculation is very clear. Whether their example of a
bimodal distribution is simply chance variation and their
treatment of non-parametric tests is questionable. Non-
normality is rarely important but inequality of variance is
much more important. It is also not true to say that para-
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metric tests are more powerful – this is generally only true
if parametric assumptions hold.
The chapter on adverse effects takes the relatively recent
CONSORT paper updating the Statement into account
and is another of the excellent chapters. The book closes
with a helpful Glossary and an Index that includes the his-
torical references (though not all the pithy aphorisms).
Overall this book is to be highly recommended to anyone
doing a course in randomised trials, and is very helpful to
anyone writing up a trial report. Since many journals use
CONSORT criteria (though not all enforce them, as noted
in the Foreword by Moher and Rennie) they would be
well advised to recommend the book to their authors.
Many of the papers on trials I have reviewed, particularly
for the British Medical Journal, over the years would be
notably improved if the authors followed the suggestions
given here.
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